STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Reed’s, Inc. Announces Closing of $10 Million Public Offering and Uplisting to NYSE American Stock Exchange

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Reed’s (NYSE American: REED) closed an underwritten public offering of 2,500,000 common shares and warrants to purchase 2,500,000 shares at a combined public offering price of $4.00 per share-plus-warrant on December 8, 2025.

Gross proceeds were approximately $10 million before underwriting discounts, commissions and expenses. Warrants are exercisable immediately at $4.50 per share and expire five years from issuance. The company also granted underwriters a 45-day option to buy up to 375,000 additional shares and/or 375,000 additional warrants. Reed’s common stock began trading on NYSE American on December 5, 2025, and ceased trading on OTCQX upon effectiveness.

Loading...
Loading translation...

Positive

  • $10 million gross proceeds from the offering
  • Listing began on NYSE American on December 5, 2025
  • Warrants exercisable immediately — potential near-term capital if exercised

Negative

  • Issued 2.5M shares plus 2.5M warrants, creating potential shareholder dilution
  • Underwriters hold a 45-day option for 375k additional shares and 375k warrants
  • Net proceeds reduced by underwriting discounts, commissions and offering expenses

Key Figures

Shares offered 2,500,000 shares Common stock in underwritten public offering
Warrants offered 2,500,000 warrants Warrants to purchase common stock in offering
Offering price $4.00 Combined price per share plus accompanying warrant
Warrant exercise price $4.50 per share Exercise price of warrants issued in offering
Gross proceeds $10 million Approximate gross proceeds before fees and expenses
Underwriters’ option period 45 days Period to buy up to 375,000 additional shares and/or warrants
Additional shares 375,000 shares Maximum extra common shares under underwriters’ option
Warrant term 5 years Warrants exercisable immediately, expiring five years from issuance

Market Reality Check

$3.23 Last Close
Volume Volume 589,474 is about 17.69x the 20-day average of 33,314, indicating heavy pre-news trading interest. high
Technical Shares at $3.17 are trading below the 200-day moving average of $7.14 and far below the $12.00 52-week high.

Peers on Argus

REED fell 50.08% previously while peers were mixed: JSDA down 0.55%, MOJO up 7.45%, others flat. This points to company-specific pressure tied to its financing and uplisting, not a broad beverage-sector move.

Historical Context

Date Event Sentiment Move Catalyst
Dec 05 Public offering priced Negative -50.1% Underwritten $10M stock-and-warrant offering and NYSE American uplisting pricing.
Oct 21 Earnings call setup Neutral +0.0% Scheduling of Q3 2025 conference call and webcast logistics.
Sep 16 Private placement Negative -3.0% $5.0M private placement at $1.00 per share for working capital.
Sep 12 Leadership changes Neutral +0.0% New CMO appointment, reorganization, and CCO resignation to support growth.
Aug 12 Q2 2025 earnings Negative +5.7% Weaker Q2 sales, margins, higher losses, and lower cash balance.
Pattern Detected

Recent capital-raising events (private placement and the NYSE American offering) coincided with negative or muted reactions, while one weak-earnings report produced a positive move, showing occasional divergence between fundamentals and price.

Recent Company History

Over the last few months, Reed’s has repeatedly tapped the capital markets, including a $5.0 million private placement in September 2025 and the $10 million underwritten public offering priced on Dec 5, 2025, which saw a -50.08% reaction. Operationally, Q2 2025 results showed weaker sales and margins and a $6.0 million net loss, yet the stock rose 5.71%. Organizational and conference-call updates had neutral price impact. Today’s closing/uplisting announcement follows directly from the Dec 5 offering terms and NYSE American approval.

Market Pulse Summary

This announcement confirms the closing of Reed’s underwritten public offering, raising approximately $10 million through 2,500,000 shares and matching warrants, and finalizing its move to NYSE American. Historically, financing steps, including the recent offering pricing and a $5.0 million private placement, have been key catalysts for the stock. Investors may watch how management deploys proceeds, subsequent balance-sheet developments, and upcoming earnings trends to assess the long-term impact of this transaction.

Key Terms

underwritten public offering financial
"closing of its previously announced underwritten public offering of 2,500,000 shares"
An underwritten public offering is when a company sells new shares of its stock to the public with the help of a financial firm, called an underwriter. The underwriter agrees to buy all the shares upfront, reducing the company's risk, and then sells them to investors. This process helps companies raise money quickly and confidently from a wide range of buyers.
warrants financial
"common stock and warrants to purchase 2,500,000 shares of common stock"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
exercise price financial
"The warrants have an exercise price of $4.50 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
registration statement on Form S-1 regulatory
"A registration statement on Form S-1 (File No. 333-291443), including a prospectus"
A registration statement on Form S-1 is a detailed filing a company submits to the U.S. securities regulator to register new shares for public sale; it includes a plain-language prospectus, financial statements, business description and risk factors. For investors it matters because it provides the official, comprehensive blueprint of the offering — like an owner’s manual — allowing buyers to assess risks, inspect financial health and compare valuation before deciding to invest.
prospectus regulatory
"A registration statement on Form S-1 ... including a prospectus, relating to these securities"
A prospectus is a detailed document that explains a company's plans for offering new shares or investments to the public. It’s important because it provides potential investors with key information about the company’s business, risks, and how they might make money, helping them decide whether to invest. Think of it as a guidebook for understanding what you're buying into.

AI-generated analysis. Not financial advice.

NORWALK, Conn., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Reed’s, Inc. (NYSE American: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, natural ginger beverages, today announced the closing of its previously announced underwritten public offering of 2,500,000 shares of its common stock and warrants to purchase 2,500,000 shares of common stock (collectively, the “Securities”). Each share of common stock and accompanying warrant to purchase one share of common stock were sold together at a combined public offering price of $4.00. The warrants have an exercise price of $4.50 per share, are exercisable immediately and will expire five years from the issuance date. In addition, Reed’s granted the underwriters a 45-day option to purchase up to an additional 375,000 shares of common stock and/or 375,000 warrants at their respective public offering prices, less underwriting discounts and commissions.

Reed’s also previously announced that, in connection with the offering, its common stock was approved for listing and began trading on the NYSE American LLC stock exchange (“NYSE American”) on December 5, 2025. Upon effectiveness of the listing on the NYSE American, trading of the common stock on the OTC Markets’ OTCQX Best Market terminated. 

“This is another milestone for Reed’s that reflects our investment in growth with a long-term path toward profitability and the value we are committed to deliver for shareholders,” said Cyril Wallace, Chief Executive Officer of Reed’s. “We believe this move to NYSE American will provide improved liquidity for our shareholders while enhancing our visibility to a broader investor base as we build on four decades of providing the world with natural, premium, better-for-you beverages.”

The gross proceeds from the offering were approximately $10 million, before deducting underwriting discounts and commissions and other offering expenses, excluding any exercise of the underwriters’ option to purchase additional Securities and any exercise of the warrants issued in the offering. 

A.G.P./Alliance Global Partners acted as the sole book-running manager, and Roberts & Ryan, Inc. acted as a co-manager for the offering.

A registration statement on Form S-1 (File No. 333-291443), including a prospectus, relating to these securities has been filed with and declared effective by the Securities and Exchange Commission (“SEC”). This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended. The offering may be made only by means of a prospectus. Electronic copies of the final prospectus may be obtained on the SEC’s website at http://www.sec.gov and may also be obtained by contacting A.G.P./Alliance Global Partners at 590 Madison Avenue, 28th Floor, New York, NY 10022, by phone at (212) 624-2060 or e-mail at prospectus@allianceg.com.

About Reed’s, Inc.

Reed’s is an innovative company and category leader that provides the world with high quality, premium and better-for-you beverages. Established in 1989, Reed's is a leader in craft beverages under the Reed’s®, Virgil’s® and Flying Cauldron® brand names. The Company’s beverages are now sold in over 32,000 stores nationwide.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the anticipated benefits of Reed’s uplisting to the NYSE American, the impact of the public offering, and Reed’s ability to achieve its business objectives and deliver long-term shareholder value. These statements are subject to significant risks and uncertainties and actual results could differ materially from those projected. Reed’s cautions investors not to place undue reliance on the forward-looking statements contained in this release. These risks and uncertainties include, without limitation, risks and uncertainties related to market conditions, the risk that the public offering will not be consummated on the terms or in the amounts contemplated or otherwise, and the satisfaction of customary closing conditions related to the public offering. Risks and uncertainties relating to Reed’s and its business can be found in the “Risk Factors” section of Reed’s annual report on Form 10-K filed on March 28, 2025, as supplemented by its quarterly report on Form 10-Q for the period ended September 30, 2025, and in the Registration Statement on Form S-1, as amended, related to the offering and declared effective by the SEC on December 4, 2025. Reed’s undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in Reed’s expectations, except as required by law.

Investor Relations Contact
Sean Mansouri, CFA or Aaron D’Souza
Elevate IR
ir@reedsinc.com
(720) 330-2829


FAQ

How many shares and warrants did Reed’s (REED) sell in the December 8, 2025 offering?

Reed’s sold 2,500,000 shares and warrants to purchase 2,500,000 shares.

What were the offering price and warrant exercise price for Reed’s (REED)?

The combined public offering price was $4.00 per share-plus-warrant; warrants exercise at $4.50 per share.

How much did Reed’s (REED) gross from the offering on December 8, 2025?

Gross proceeds were approximately $10 million before underwriting discounts and expenses.

When did Reed’s (REED) common stock begin trading on NYSE American?

Trading on NYSE American began on December 5, 2025, and OTCQX trading terminated upon effectiveness.

Do the Reed’s (REED) warrants have an expiration and immediate exercisability?

Yes; the warrants expire five years from issuance and are exercisable immediately.

Can underwriters buy more Reed’s (REED) securities after the offering closes?

Yes; underwriters have a 45-day option to purchase up to 375,000 additional shares and/or 375,000 additional warrants.
Reeds

OTC:REED

REED Rankings

REED Latest News

REED Latest SEC Filings

REED Stock Data

49.16M
8.07M
58.67%
2.74%
4.27%
Beverages - Non-Alcoholic
Consumer Defensive
Link
United States
Norwalk